Simulations Plus Inc (SLP)

Currency in USD
18.50
0.00(0.00%)
Closed·
Showing Simulations Plus historical data. For real-time data please try another search
Fair Value
Day's Range
18.4918.50
52 wk Range
11.0921.01
Key Statistics
Prev. Close
18.5
Open
18.5
Day's Range
18.49-18.5
52 wk Range
11.09-21.01
Volume
625.31K
Average Volume (3m)
296.28K
1-Year Change
12.1212%
Book Value / Share
6.88
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SLP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Simulations Plus Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Simulations Plus Inc SWOT Analysis


Software Resilience
Explore SLP's robust software segment, showcasing 8% organic growth and a 10% increase in average revenue per customer, highlighting its essential role in pharmaceuticals
Service Sector Challenges
Delve into the headwinds facing SLP's service segment, including client-driven delays and a significant contract cancellation impacting revenue forecasts
Strategic Positioning
Learn how SLP maintains a competitive edge with its comprehensive software suite, trading at a premium compared to competitors despite recent market challenges
Future Prospects
Discover SLP's revised outlook, with analyst price targets ranging from $28 to $41 per share, and potential opportunities arising from evolving FDA regulations
Read full SWOT analysis

Simulations Plus Inc Earnings Call Summary for Q2/2026

  • Q2 FY2026 EPS of $0.35 beat forecast by 12.9%; revenue of $24.3M exceeded expectations by 12.19%, up 8% YoY with software sales driving growth.
  • Gross margin improved to 66% from 59% prior year; adjusted EBITDA reached $8.7M with 36% margin, reflecting strong cost management and operational efficiency.
  • Software segment grew 9% YoY, representing 60% of total revenue; strategic AI integration and pharma collaborations expected to fuel future expansion.
  • FY2026 guidance reaffirmed: total revenue projected at $79M-$82M with adjusted EPS range of $0.75-$0.85, driven by AI capabilities and partnerships.
  • Stock rose 0.31% after-hours to $13.04; risks include market saturation, regulatory changes, macroeconomic pressures, and client concentration concerns.
Last Updated: 10/04/2026, 07:58 am
Read Full Transcript

Earnings

Latest Release
09/07/2026
EPS / Forecast
0.30 / 0.23
Revenue / Forecast
21.9M / 20.93M
EPS Revisions
Last 90 days

SLP Income Statement

Compare SLP to Peers and Sector

Metrics to compare
SLP
Peers
Sector
Relationship
P/E Ratio
46.2x0.0x−0.3x
PEG Ratio
0.410.000.00
Price/Book
2.7x0.0x2.6x
Price / LTM Sales
4.6x0.0x2.9x
Upside (Analyst Target)
−6.8%0.0%65.2%
Fair Value Upside
Unlock0.0%9.1%Unlock

People Also Watch

327.28
IDCC
-1.44%
176.04
VICR
-2.19%
10.33
CERT
+2.38%
4.17
WRD
+0.97%
815.31
FICO
-0.97%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.